Metropolitan Life Insurance Company (MetLife)’s Alkami Technology ALKT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ALKT Stock Details ALKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,322	Closed	-$57.1K	–	98
2024 Q1	$57.1K	Hold	2,322	–	–	﹤0.01%	1338
2023 Q4	$56.3K	Sell	2,322 -322	-12%	-$6.71K	﹤0.01%	1384
2023 Q3	$48.2K	Buy	2,644 +445	+20%	+$7.48K	﹤0.01%	1423
2023 Q2	$36K	Buy	2,199 +295	+15%	+$4.07K	﹤0.01%	1617
2023 Q1	$24.1K	Sell	1,904 -427	-18%	-$6.3K	﹤0.01%	1782
2022 Q4	$34K	Buy	2,331 +197	+9%	+$2.75K	﹤0.01%	1710
2022 Q3	$32.1K	Hold	2,134	–	–	﹤0.01%	1755
2022 Q2	$29.6K	Hold	2,134	–	–	﹤0.01%	1826
2022 Q1	$30.5K	Sell	2,134 -6,338	-75%	-$96.8K	﹤0.01%	1872
2021 Q4	$170K	Buy	+8,472	New	+$217K	﹤0.01%	2136

Other funds holding ALKT

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACL

Azora Capital LP Miami, Florida $1.52B AUM 39.16% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ALKT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Alkami Technology (ALKT) in Q2 2024, closing a stake of 2,322 shares — an estimated $57.1K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ALKT in Q4 2021 and held it in 10 quarters. The position peaked at $170K in Q4 2021. 171 funds tracked by Wall St. Rank hold ALKT as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Alkami Technology position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 2,322 Alkami Technology shares in Q2 2024, an estimated $57.1K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Alkami Technology in Q4 2021 and held it in 10 quarters.
Metropolitan Life Insurance Company (MetLife)'s Alkami Technology position peaked at $170K in Q4 2021.
171 funds tracked by Wall St. Rank held Alkami Technology as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.